Government gives approval for three new AIIMS

Published On 2015-10-08 08:05 GMT   |   Update On 2021-08-19 10:49 GMT

Three new All India Institutes of Medical Sciences (AIIMS) will be set up after the union cabinet gave its consent for the move, involving financial implications of Rs 4.949 crore.With the prime objective to offer premier healthcare services in as many states as possible, this time the premise for new AIIMS centre will be Nagpur in Maharashtra, Manglagiri in Andhra Pradesh and Kalyani in...

Login or Register to read the full article
Three new All India Institutes of Medical Sciences (AIIMS) will be set up after the union cabinet gave its consent for the move, involving financial implications of Rs 4.949 crore.

With the prime objective to offer premier healthcare services in as many states as possible, this time the premise for new AIIMS centre will be Nagpur in Maharashtra, Manglagiri in Andhra Pradesh and Kalyani in West Bengal.

The new AIIMS would be set up under the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY), which involves financial implications of Rs.4,949 crore.

While the new AIIMS at Manglagiri will cost Rs. 1,618 crore, that at Nagpur will cost Rs.1,577 crore and at Kalyani Rs. 1,754 crore.

The three new AIIMS would address regional imbalances in the availability of affordable and reliable tertiary health care services in these regions.

The cabinet meeting was chaired by Prime Minister Narendra Modi.

"The proposed institutions shall have hospitals with a capacity of 960 beds. In addition, there shall be teaching, administrative and AYUSH blocks, auditoriums, nursing colleges, night shelters, hostels and residential facilities," said an official statement.

"These will augment quality medical education and also address shortfall of health care professionals in these regions. Large populations of Andhra Pradesh, Maharashtra (Vidarbha) and West Bengal along with people in adjoining states will benefit from the projects," said the statement.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News